Who we are
Our mission? To revolutionize the treatment of serious and, to date, incurable diseases through the development of innovative anti-gene therapies. Biogenera’s vision is to be at the forefront of biopharmaceutical science, improving the lives of patients around the world.
Team & Leadership
Board of Directors
MASSIMILIANO CESARINI
Chairman of the Board & CEO
VALENTINA BERTUCCIOLI
Vice-Chairman & Executive Board Member
NICOLO’ BRIANTE
Executive Board Member & Chief Legal Officer
GABRIELE LATTANZIO
Board Member &
Chief Financial Officer
FRANCESCA NATALI
BOARD MEMBER
ALBERTO PULLINI
BOARD MEMBER
Scientific Strategy Advisors
Countries
Biogenera holds a robust and internationally recognized patent portfolio, ensuring full freedom-to-operate across major global jurisdictions. With 48 granted patents in 46 countries and additional applications pending approval, our IP covers MyGenera™, BGA002, BGA003, and other drug candidates in development. This strong protection validates the scientific value of our technologies and reinforces our long-term commitment to advancing therapeutic innovation in oncology.
48
Countries
46
Paesi
7 Drug candidates
1 pending approval
Sustainability and Social Responsibility
We are committed every day to research and development activities, carried out responsibly. Biogenera adopts sustainable strategies to minimize environmental impact and maximize social well-being. Discover how our social responsibility is integrated with our corporate mission.
English 
Italian